NCCN Guidelines for Patients® | Esophageal Cancer - page 42

42
NCCN Guidelines for Patients
®
: Esophageal Cancer
Version 1.2013
Part 5: Squamous cell carcinomas
This chart lists the treatment options for when surgery
can’t be done. For a Tis tumor, endoscopic treatment—
EMR or ablation—is a safe option. EMR followed by
ablation can remove T1a and T1b tumors. Instead of
endoscopic treatment, chemoradiation may be given for
a T1b tumor that may have spread beyond the reach of
endoscopic treatment. The recommended chemotherapy
regimens for chemoradiation are:
Preferred regimens
• Cisplatin and fluoropyrimidine (5-FU or capecitabine)
• Oxaliplatin and fluoropyrimidine (5-FU or
capecitabine)
• Paclitaxel and carboplatin
Other regimens
• Paclitaxel and cisplatin
• Docetaxel and cisplatin
• Irinotecan and cisplatin
• Paclitaxel and fluoropyrimidine (5-FU or
capecitabine)
• Docetaxel and fluoropyrimidine (5-FU or
capecitabine)
Next steps:
When you are finished with cancer
treatment, read Part 5.3 for follow-up testing.
Nonsurgical options
TNM scores
Primary treatment
Tis, N0, M0
T1a, N0, M0
Ablation
EMR, or
T1b, N0, M0
EMR then ablation
Chemoradiation
EMR then ablation, or
1...,32,33,34,35,36,37,38,39,40,41 43,44,45,46,47,48,49,50,51,52,...100
Powered by FlippingBook